FindTrial
Sign In

Comparison of oxidative stress in anemic and non-anemic pregnant women receiving oral iron supplements in a Tertiary Care Hospital in Belagavi

A comparative study of oxidative stress in anemic and non-anemic pregnant women receiving oral iron supplements in a Tertiary Care Hospital in Belagavi - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094823
Enrollment
140
Registered
2025-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O280- Abnormal hematological finding onantenatal screening of mother

Interventions

Intervention1: Anemic pregnant women taking iron supplements: Anemic (Hb-7-10.9gm percent) pregnant women will be given oral iron which contains 60mg elemental iron twice daily Intervention2: Nil: Nil

Sponsors

Dr Mansa Priyadarshini
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women with singleton pregnancy with mild-moderate anemia (Hb 7-10.9gm percent) Non-anemic Pregnant women with singleton pregnancy Written informed consent

Exclusion criteria

Exclusion criteria: Pregnant women having 1.) Pre existing chronic diseases eg Diabetes Mellitus, Chronic Hypertension, Cardiovascular diseases, Chronic Kidney Disease, Thyroid disorders, Autoimmune disorders (eg- lupus, rheumatoid arthritis) 2.) Other Hematological disorders eg- Sickle cell anemia, Thalassemia, Hemolytic anemia, Bleeding disorders 3.) Severe infections or inflammatory conditions eg- Active infections like tuberculosis, HIV, hepatitis B/C 4.) Use of medications affecting oxidative stress or iron metabolism eg Long term corticosteroids, Antioxidant supplements (like vitamin C, E), Anti-inflammatory drugs (NSAID s or immunosuppresants), Anti epileptic drugs, Chemotherapy drugs, Antiretroviral drugs, Antibiotics (Gentamicin, Metronidazole), Antacids, chelating agents, anticoagulants, aspirin, zinc and copper supplements 5.) Multiple pregnancy 6.) Iron overload disorders (eg- hemochromatosis) 7.) Smoking, Alcohol, Drug abuse 8.) Severe malnutrition or dietary restrictions (BMI smaller than 18.5kg/m2-underweight) 9.) Obese (BMI greater than 30kg/m2) 10.) Refusal to give consent

Design outcomes

Primary

MeasureTime frame
Oxidative stress in anemic and nonanemic pregnant women due to iron supplementationTimepoint: At 14-20wks (Before starting iron supplementation) and 3-6 wks after starting iron supplementation—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactMansa Priyadarshini

Jawaharlal Nehru Medical College, KLE University, Belagavi

romiarif@gmail.com9964892744

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026